Neuroone Medical Technologies (NMTC) EBT Margin Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 7,654.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,654.00 |
| Dec 31, 2025 | -10,424.00 |
| Sep 30, 2025 | 117,148.00 |
| Jun 30, 2025 | 24,665.00 |
| Mar 31, 2025 | 4,354.00 |
| Dec 31, 2024 | 39,666.00 |
| Sep 30, 2024 | -80,790.00 |
| Jun 30, 2024 | 21,554.00 |
| Mar 31, 2024 | 54,839.00 |
| Dec 31, 2023 | 117,015.00 |
| Sep 30, 2023 | 157,529.00 |
| Jun 30, 2023 | 806,028.00 |
| Mar 31, 2023 | 760,334.00 |
| Dec 31, 2022 | 680,665.00 |
| Sep 30, 2022 | 347,236.00 |
| Jun 30, 2022 | -124,961.00 |
| Mar 31, 2022 | 476,551.00 |
| Dec 31, 2021 | -557,741.00 |
| Mar 31, 2015 | -768,802.00 |
| Jun 30, 2014 | -104,689.00 |
| Mar 31, 2014 | -174,765.00 |
| Mar 31, 2013 | 297,706.00 |
| Dec 31, 2012 | 482,774.00 |
| Sep 30, 2012 | -2.03 Mn |
| Mar 31, 2012 | -357,393.00 |